Invesco’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-201,616
Closed -$14.5M 4022
2020
Q4
$14.5M Buy
201,616
+15,836
+9% +$829K ﹤0.01% 1603
2020
Q3
$8.47M Sell
185,780
-36,654
-16% -$1.53M ﹤0.01% 1733
2020
Q2
$10.1M Sell
222,434
-7,505
-3% -$336K ﹤0.01% 1631
2020
Q1
$8.85M Sell
229,939
-913,870
-80% -$42.1M ﹤0.01% 1590
2019
Q4
$53M Sell
1,143,809
-46,186
-4% -$2M 0.02% 994
2019
Q3
$48.5M Sell
1,189,995
-85,577
-7% -$3.69M 0.01% 1010
2019
Q2
$61.4M Sell
1,275,572
-172,005
-12% -$9.04M 0.02% 935
2019
Q1
$90.6M Buy
1,447,577
+59,213
+4% +$4.07M 0.03% 567
2018
Q4
$82.9M Sell
1,388,364
-260,316
-16% -$15.6M 0.03% 545
2018
Q3
$106M Buy
1,648,680
+408,585
+33% +$22.8M 0.03% 536
2018
Q2
$55.8M Buy
1,240,095
+1,055,677
+572% +$42.1M 0.02% 806
2018
Q1
$5.73M Buy
184,418
+95,998
+109% +$3.16M ﹤0.01% 1870
2017
Q4
$2.64M Buy
88,420
+7,962
+10% +$231K ﹤0.01% 2389
2017
Q3
$2.65M Sell
80,458
-6,306
-7% -$218K ﹤0.01% 2361
2017
Q2
$2.9M Buy
86,764
+4,493
+5% +$134K ﹤0.01% 2286
2017
Q1
$2.38M Buy
82,271
+2,078
+3% +$51.5K ﹤0.01% 2466
2016
Q4
$1.79M Sell
80,193
-36,109
-31% -$706K ﹤0.01% 2659
2016
Q3
$2.16M Buy
116,302
+64,961
+127% +$1.23M ﹤0.01% 2502
2016
Q2
$837K Buy
+51,341
New +$755K ﹤0.01% 2999
2015
Q3
Sell
-562
Closed -$5K 4293
2015
Q2
$5K Buy
+562
New +$5.2K ﹤0.01% 4265
2014
Q4
Sell
-12,647
Closed -$85K 4194
2014
Q3
$85K Sell
12,647
-2,594
-17% -$18.2K ﹤0.01% 3874
2014
Q2
$109K Sell
15,241
-4,923
-24% -$39.2K ﹤0.01% 3898
2014
Q1
$203K Buy
20,164
+7,016
+53% +$64.6K ﹤0.01% 3740
2013
Q4
$104K Sell
13,148
-39,732
-75% -$371K ﹤0.01% 4014
2013
Q3
$524K Sell
52,880
-67,600
-56% -$532K ﹤0.01% 3385
2013
Q2
$710K Buy
+120,480
New +$405K ﹤0.01% 3105

Other funds holding BEAT

Invesco's BEAT Position: Q1 2021 in Review

Invesco sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 201,616 shares — an estimated $14.5M sold.

Invesco first reported a position in BEAT in Q2 2013 and held it in 26 quarters. The position peaked at $106M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Invesco reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Invesco sold 201,616 BioTelemetry, Inc. shares in Q1 2021, an estimated $14.5M.
  • Invesco first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 26 quarters.
  • Invesco's BioTelemetry, Inc. position peaked at $106M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Invesco's 13F filing for Q1 2021, filed 17 May 2021.